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SUMMARY  The aim of the study was to evaluate the possible use of 
atopy patch test in the diagnosis of atopic dermatitis and to characterize 
an optimal standardized system for atopy patch test in terms of allergen 
concentrations and time of allergen exposure. The study included 36 
patients with atopic dermatitis and IgE-mediated airborne allergy. 
Patients presented positive results of skin prick tests and serum antigen 
speciﬁc IgE against house dust mite allergens and/or selected grass 
pollen allergens. Control groups consisted either of patients with allergic 
rhinitis (control group 1) or healthy volunteers with no signs or symptoms 
of atopy (control group 2). Allergologic diagnostic workup consisted of 
skin prick test, serum antigen speciﬁc IgE and total IgE evaluation, atopy 
patch test with selected airborne allergens of different concentrations 
(0.1xSPT, 1xSPT and 10xSPT), time of allergen exposure (8, 24 and 28 
h), and readings of the results (8, 24, 48 and 72 h). Positive results of 
atopy patch test with airborne allergens were obtained in 47.2% of atopic 
dermatitis patients and none of control subjects. Contact reaction itself 
and the intensity of reaction were demonstrated to correlate with allergen 
concentration and time of allergen exposure on atopy patch test. The 
dose and time response analysis showed the optimal concentration 
of allergens for atopy patch test to be 10xSPT - 500000 SBE/ml, and 
optimal evaluation time 24 and 48 h of allergen application. There 
was no correlation between atopy patch test results and mean serum 
concentrations of total or antigen speciﬁc IgE. Atopy patch test results did 
not correlate with localization of skin lesions, severity and extensiveness 
of skin inﬂammation. A signiﬁcantly higher contact reactivity to airborne 
allergens was recorded in the group of atopic dermatitis patients with 
polyvalent allergy in comparison with atopic dermatitis patients allergic 
to only one aeroallergen. It is concluded that atopy patch test is the only 
provocation test currently available with clinical relevance for contact IgE-
mediated sensitization in atopic dermatitis patients. Using petrolatum as 
a vehicle, allergen concentration of 500000 SBE/ml and  evaluation time 
of 24 and 48 h of allergen application may lead to improved atopy patch 
test results.                     
KEY WORDS: airborne allergens; atopy patch test; atopic dermatitis; 
standardization
4 INTRODUCTION
 Skin inﬂammation in patients suffering from 
atopic dermatitis (AD) may be aggravated after 
exposure to environmental allergens and may 
improve with allergen avoidance (1-3). Airborne 
allergens like house dust mites (HDM), plant 
pollen allergens, animal epithelia or moulds may 
be responsible for severe exacerbations of skin 
lesions in AD patients and there are basically two 
possible routes of such an inﬂuence. One route is by 
inhalation and so far only a few allergen inhalation 
studies in patients with AD were performed (4,5). 
Another route which seems to be more important 
is by skin contact with environmental allergens. 
An increasing number of reports indicate that 
in selected patients with AD, eczematous skin 
lesions can be induced after epicutaneous patch 
testing with airborne allergens  (e.g., HDM) (6-
10). For this procedure, epicutaneous patch 
test with airborne allergens known to elicit IgE-
mediated reactions and evolution of eczematous 
skin lesions, the term atopy patch test (APT) has 
been proposed (6,11,12). It seems that airborne 
allergens after penetrating the skin may bind to 
FcεR1-bound IgE on Langerhans cells, which 
subsequently can present the antigens to T cells 
leading to activation of Th2 subpopulation in an 
acute stage and Th1 subpopulation in case of 
chronic stage of the reaction (13-15). 
 Studies on patch testing with airborne allergens 
were ﬁrst carried out by Mitchel et al. (16) in 1982. 
Further investigations and scientiﬁc projects 
varied widely in the methods used. Skin abrasion 
(8,16,17), tape stripping (10,18) and sodium lauryl 
sulfate (SLS) application (19) were frequently used 
in order to increase allergen penetration. There 
were also studies on APT applied on nonabraded, 
nonpretreated skin (6,12,20,21) reporting different 
frequency of positive APT reaction. Different 
results were also related to various allergen 
concentrations in the preparations used for APT. 
 It seems that the variables in studies on APT that 
might have affected the outcome of testing  were 
allergen concentrations, tape stripping, reading 
time and application site. Therefore, the ﬁrst 
objective of our study was to re-evaluate the effects 
of the main variables, i.e. allergen concentrations 
and time of exposure.
 The occurrence of positive APT in atopic 
patients without AD has been reported by some 
authors (22,23), therefore the second objective of 
the study was to evaluate the frequency of positive 
APT reaction in AD patients and to determine 
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whether APT reaction was only speciﬁc for this 
population. The third objective was to analyze the 
results of APT in relation to the clinical course of 
AD, and ﬁnally to assess the correlation of APT 
results with other allergologic evaluations of IgE-
mediated reaction.
 MATERIAL AND METHODS 
 Patients and control subjects
 Thirty-six patients with AD (22 female and 14 
male) aged 6-45 (mean age 19) years, diagnosed 
and treated at Allergic Diseases Diagnostic Center 
and Department of Dermatology, University 
of Medical Sciences in Poznań, Poland, were 
selected for the study. Patients were recruited 
according to the following inclusion criteria: 
monovalent or polyvalent type of IgE-mediated 
airborne allergy diagnosed on the basis of clinical 
course of AD (exacerbations of skin inﬂammation 
after exposure to airborne allergens); results 
of SPT and evaluations of antigen speciﬁc IgE 
(asIgE) directed against common aeroallergens; 
clinical remission of AD symptoms at the time 
of APT; at least 12 months free from systemic 
glucocorticotherapy, phototherapy and allergen 
speciﬁc immunotherapy; and at least 2 weeks free 
from antihistamine administration.
 Control groups consisted of 25 adults: control 
group 1 of 10 patients (6 female and 4 male) with 
allergic rhinitis (seasonal or perennial) aged 8-45 
(mean age 21); and control group 2 of 15 healthy 
volunteers (9 female and 6 male) aged 7-49 (mean 
age 20) years, with no signs and symptoms of 
atopy.
 Physical examination in patients with AD 
 AD was diagnosed according to Haniﬁn 
and Rajka criteria and in all cases complete 
physical examination was performed. Case 
history included the following elements: onset 
of the disease (patient age); coexistence of any 
other atopic diseases; family history of atopic 
diseases; exacerbations of skin inﬂammation after 
exposure to airborne allergens; seasonal course 
of exacerbations; treatment applied during the 
previous year; and coexistence of any systemic 
pathologies or administration of any therapies that 
might inﬂuence study results. Clinical evaluation 
of patients with AD was based on W-AZS index 
(Severity and extensiveness of skin inﬂammation 
in AD score) proposed by Silny et al. (24).
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I EVALUATION OF PRURITUS AND LOSS OF SLEEP IN PATIENTS WITH ATOPIC DERMATITIS       
 A. PRURITUS EVALUATION:
        POINTS 
   No pruritus .........?
   Pruritus is present:
    Extensiveness:
  1. Single or multiple localization of pruritus ........................................................................... 2
  2. Extensive pruritus involving the whole body surface ......................................................... 6 
 Frequency:
  1. Short episodes of pruritus – less than 30 minutes ............................................................. 2 
  2. Longlasting pruritus episodes ............................................................................................ 4 
  3. C?  8 
 Severity:
  1. Scratching is not necessary  .............................................................................................. 2 
  2. Scratching is necessary  .................................................................................................... 4 
  3. Anxiety and irritation caused by pruritus ............................................................................ 8 
B. LOSS OF SLEEP EVALUATION
  1. No?   0   
  2. Problems in falling asleep  ................................................................................................  3
  3. Night awakening caused by pruritus .................................................................................   6 
  4. Slee?
          TOTAL I = A + B
II EVALUATION OF EXTENSIVENESS AND SEVERITY OF SKIN INFLAMMATION IN PATIENTS 
WITH ATOPIC DERMATITIS
• Score extensiveness of skin lesions from 0 to 3:
 0 = absent
 1 = 1%-10% of skin surface involved 
 2 = 11%-30% of skin surface involved 
 3 = 31%-100% of skin surface involved
• Score severity of skin inﬂammation from 0 to 3:
 0 = absent
 1 = mild 
 2 = moderate
 3 = severe
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TOTAL W-AZS : I +II 
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Severity of skin inﬂammation
TOTAL ..... 
6 Skin prick test
 SPT was performed with 20 airborne allergens 
(Nexter Allergopharma, Reinbek, Germany) such 
as: Dermatophagoides pteronyssinus 50000 SBE/
ml; Dermatophagoides farinae 50000 SBE/ml; 
cultivated rye 50000 SBE/ml; timothy grass 50000 
SBE/ml; rye grass 50000 SBE/ml; meadow fescue 
50000 SBE/ml. Results of SPT were evaluated 
after 20 minutes according to the following scale:
0 reaction to allergen equal to negative control;
+ mean diameter of allergen-induced wheal 
bigger than negative control but smaller than 
histamine-induced wheal;
++  mean diameter of allergen-induced wheal 
bigger than half or nearly equal to the mean 
diameter of  histamine-induced wheal;
+++ mean diameter of allergen-induced wheal 
equal or slightly bigger than the mean diameter of 
histamine-induced wheal;
++++ mean diameter of allergen-induced wheal 
at least twice as big as the mean diameter of 
histamine-induced wheal, and all pseudopodial 
reactions.
Results evaluated as ++, +++ and ++++ were 
recorded as positive, and those evaluated as 0 
and + as negative.
 Total and antigen speciﬁc IgE evaluations
 Serum levels of total and asIgE were measured 
by use of CAP-FEIA system (Pharmacia, Uppsala, 
Sweden). Serum samples were collected on the 
ﬁrst day of APT from each patient with AD and 
allergic rhinitis. Evaluation criteria for asIgE serum 
concentrations were as follows :
class 0:   conc.<0.35 kU/l;
class 1:   conc. 0.35-0.7 kU/l (low conc.);
class 2:   conc. 0.7-3.5 kU/l (medium conc.);
class 3:   conc. 3.5-17.5 kU/l (high conc.);
class 4:   conc. 17.5-50 kU/l (very high conc.);
class 5:   conc. 50-100 kU/l (very high conc.);
class 6:   conc. >100 kU/l (very high conc.);
 Results evaluated as class 3, 4 ,5 and 6 were 
recorded as positive.
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 Atopy patch tests 
 APTs were performed with the following airborne 
allergens: Dermatophagoides pteronyssinus, 
Dermatophagoides farinae, cultivated rye, timothy 
grass, rye grass and meadow fescue. Lyophilized 
airborne allergens and solvent composed of 
0.9% NaCl with the addition of 0.4% phenol were 
supplied by Allergopharma, Reinbek, Germany. 
These allergens were used in concentrations of 
1xSPT concentration (50000 SBE/ml),  10xSPT 
concentration (500000 SBE/ml) and 0.1xSPT 
concentration (5000 SBE/ml). The vehicle for APT 
allergens was composed of Eucerini anhydrati and 
vaselini albi aa and control reaction was evaluated 
with the vehicle and solvent.
Allergens were applied on clinically uninvolved, 
untreated back skin in Finn Chambers on Scanpor 
(diameter 12 mm; Epitest Ltd., Oy, Finland). 
Results were evaluated at 8, 24, 48 and 72 hours 
of allergen application. 
APT results were evaluated according to the 
following scale:
0 no reaction;
+ erythema, no edematous papules;
++ erythema, inﬂammatory inﬁltration, singular 
edematous papules;
+++ erythema, multiple edematous papules, 
singular vesicles;
++++ intensive inﬂammatory inﬁltration, multiple 
vesicles.
 In the group of 36 patients with AD 
and in 10 patients with allergic rhinitis the 
following investigations were performed: SPT 
(Allergopharma, Reinbek, Germany); serum total 
IgE (FEIA CAP System, Pharmacia, Uppsala, 
Sweden); serum asIgE evaluation (FEIA CAP 
System, Pharmacia, Uppsala, Sweden); and APT. 
The group of 15 healthy volunteers underwent SPT 
(Allergopharma, Reinbek, Germany) and APT.
 Statistical analysis 
 Statistical analysis was performed by use of 
Mann-Whitney nonparametric test, Spearman 
nonparametric correlation coefﬁcient, Fisher or 
Fisher-Freeman-Halton test and u-Gauss test. 
Calculations were performed with STATISTICA v 
5.5 and StatXact-3.
7 RESULTS 
 Results of clinical evaluation in AD patients
 In patients with AD and IgE-mediated airborne 
allergy, exacerbations of skin inﬂammation after 
exposure to airborne allergens such as HDM or 
plant pollen allergens can be expected. In such 
cases, localization of skin lesions at least at the 
starting point of the reaction should include so-
called “airborne” regions like face, neck, upper 
trunk, forearms, etc. In our study, 25 (69%) AD 
patients reported periodical exacerbations after 
exposure to airborne allergens. In this population 
house dust was considered to be the causative 
factor in 13 (36%) patients, seasonal exacerbations 
after exposure to grass pollen allergens were 
recorded in 8 (22%) patients, whereas four (11%) 
patients described exacerbations of clinical status 
after exposure to both HDM and pollen allergens. 
In the group of 26 patients with well documented 
IgE-mediated allergy to D. pteronyssinus and D. 
farinae, 17 (65%) patients noticed exacerbations 
of the inﬂammatory process after exposure to the 
allergens; the same phenomenon was observed 
in 12 (67%) subjects from the group of 18 AD 
patients allergic to grass pollen allergens.
 On clinical evaluation of AD patients, we 
analyzed localization of skin lesions according to 
airborne regions. Twenty-seven (75%) patients 
presented typical airborne localization of skin 
inﬂammatory lesions (“protected” regions, 25%). 
 The clinical score of AD patients ranged from 3 
to 100 points (W-AZS maximal value 178 points, 
median 21.2 points). Patients were then divided 
into two subgroups according to W-AZS score: 
group 1, mild severity (up to 40 points) and group 
2, moderate severity (over 40 points). Mild severity 
of AD process (median 16 points) was recorded in 
27 (75%) and moderate severity of AD (median 
61.3 points) in the remaining nine (25%) patients.
 Results of skin prick tests
 In the population of all AD patients (n=36), 
positive SPT results with HDM allergens and 
negative with grass pollen allergens were recorded 
in 18 patients, whereas ten patients showed 
positive SPT results for grass pollen allergens and 
negative SPT with HDM allergens. In eight AD 
patients SPT results were positive for both HDM 
and grass pollen allergens.
 In control group 1 (allergic rhinitis), three 
patients showed positive SPT with HDM allergens 
(in two patients SPT result was positive for D. 
pteronyssinus and D. farinae; in one patient 
SPT was positive for D. pteronyssinus allergen 
only). For grass pollen allergens SPT results 
were positive in ﬁve AD patients. In total, positive 
SPT results for D. pteronyssinus allergens were 
recorded in 26 AD patients and ﬁve patients with 
allergic rhinitis. Positive SPT results for D. farinae 
were obtained in 26 AD patients and four allergic 
rhinitis patients. SPT with grass pollen allergens 
(rye grass, timothy grass and cultivated rye) 
produced positive results in 18 AD patients and 
six patients with allergic rhinitis. In control group 
2 (healthy volunteers), SPT results were negative 
with all tested allergens. The characteristics of 
skin reactivity (point scale) to selected airborne 
allergens in AD patients are presented in Table 1. 
Most patients showed well deﬁned positive skin 
reactivity on SPT testing (+++ or ++++).
Table 1. Evaluation of skin reaction to selected 
airborne allergens in skin prick test (SPT) in the 
group of atopic dermatitis patients
   ++ +++ ++++
D. pteronyssinus
(n=28)   1* 13 14
D. farinae
(n=28)   3 13 12
Rye grass
(n=18)   1 8 9
Timothy grass
(n=18)   1 7 10
Meadow fescue
(n=18)   1 7 10
Cultivated rye
(n=18)   1 5 12
*patient with mild reaction to D. farinae allergens
SPT reaction to selected airborne aller-
gens (results presented by point scale)
Results of serum IgE evaluation
 Results of total and asIgE evaluations in 
serum of AD patients and control group 1 are 
presented in Table 2. The mean concentration of 
total IgE was signiﬁcantly higher in AD patients 
(998.5±813.7 kU/l) than in control group 1 (allergic 
rhinitis; 397.7±590.4  kU/l; p<0.05). Serum asIgE 
directed against selected airborne allergens 
were detectable in all AD patients. The mean 
concentration of serum asIgE for grass pollen 
allergens was comparable in AD patients and 
allergic rhinitis patients. The mean concentration 
of asIgE directed against HDM allergens was 
higher in AD patients, however, without statistical 
signiﬁcance.
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8 Results of atopy patch tests
 Patients with positive APT reaction were older 
than patients with negative APT results (mean age 
21.9±11.5 vs 16.6±7.69 years). This difference 
was not statistically signiﬁcant. APT reaction was 
positive in 17 (47.2%) AD patients and negative 
in all subjects from both control groups (p<0.05). 
In AD patients APT results correlated with the 
concentration of allergens used on testing and time 
of skin exposure to airborne allergens (Table 3). 
Nine patients showed reaction to a concentration of 
0.1xSPT, 16 patients to a concentration of 1xSPT, 
and 17 patients to a concentration of 10xSPT. The 
following pattern of correlation with the time of 
allergen exposure was observed: with the lowest 
concentration of allergens, no reaction occurred 
after 8 h, four patients reacted after 24 h and eight 
patients after 48 h of exposure; with a concentration 
equal to SPT allergen concentration, the respective 
ﬁgures were one, eight and 11 patients; and with a 
concentration of 10xSPT reaction occurred at the 
respective time points in two, 15 and 16 patients. 
According to time of exposure, positive reaction 
was recorded in three patients at 8 h, in 15 patients 
at 24 h, and in 16 patients at 48 h of exposure to 
airborne allergens. At 8 h of exposure, there was 
no reaction to a concentration of 0.1xSPT; there 
was 1 reaction to 1xSPT concentration and 2 cases 
Table 2. Mean serum concentrations of total and antigen speciﬁc IgE (kU/l) ± SD in atopic dermatitis 
patients and control group 1
Table 3. Number and percentage of atopic dermatitis patients with positive APT results according to 
different allergen concentrations and exposure time points
8 h 24 h 48 h
Total number of  patients with  positive 































Total number of patients with  
positive results in different 
exposure time subgroups
3 15 16
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a/a  - p <0.05
b/b   - NS
c/c   - NS
d/d  - NS
e/e  - NS
f/f   - NS
g/g  - NS
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9of positive reaction to 10xSPT concentration. 
At 24 h or exposure, four patients reacted to a 
concentration of 0.1xSPT, eight patients to a 
concentration of 1xSPT, and 15 patients to the 
highest concentration of 10xSPT. The longest time 
of exposure to airborne allergens (48 h) resulted in 
8 positive reactions to the lowest concentration, 11 
positive reactions to the concentration of 1xSPT 
and 16 positive reactions to the highest allergen 
concentration of 10xSPT.
 All AD patients underwent APT with multiple 
airborne allergens (2-6 allergens). Patients showed 
various reactions to different allergens of equal 
concentrations after the same periods of exposure. 
Patients were considered as reacting positively 
in case of at least one reaction to the airborne 
allergen tested. This method of calculation may 
be somehow misleading, therefore we decided 
to calculate all positive reactions to the allergens 
not in consideration for particular patients. Results 
were then summed up, are discussed below and 
presented in Tables 4 and 5.
 Further analysis of APT results according 
 to allergen concentration used and time of 
 exposure
 APT results according to allergen concentrations 
at different time points are presented in Table 4. 
In total, we recorded 27 reactions to the lowest 
concentration, 65 reactions to the medium 
concentration, and 107 positive reactions to the 
highest concentration of tested allergens. Statistical 
analysis of the results revealed a signiﬁcant 
increase of positive results with the increase in 
airborne allergen concentrations. Then, the results 
were analyzed according to the three different 
periods of exposure (Table  5). Prolongation of 
the period of exposure resulted in an increase in 
the rate of positive reactions to airborne allergens. 
In total, we recorded 7 reactions at 8 h, 81 
reactions at 24 h and 111 positive reactions at 48 
h of exposure. Statistical analysis of these results 
yielded a signiﬁcant increase in the rate of positive 
results with exposure prolongation. Correlation 
between APT reaction and time of exposure for 
different allergen concentrations is illustrated in 
Figure 1.
Table 4. Number and percentage of positive APT reactions in atopic dermatitis patients and results of 
comparative statistical analysis according to allergen concentrations tested
Time of exposure Positive reactions
(number of cases)
Statistical 





























Table 5. Number of positive APT reactions in atopic dermatitis patients and results of statistical 
comparative analysis according to time of exposure to airborne allergens
Concentration of allergens Positive reactions
(number of cases)
Statistical 
signiﬁcance 0.1xSPT 1xSPT 10xSPT
8 h 0 1 6 7a    a/b - p=0.00001
24 h 8 25 48 81b    a/c - p=0.00001
48 h 19 39 53 111c
 b/c - p=0.0012
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 Table 4 and Figure 2 present percentage 
of positive reactions at each time of exposure 
evaluated relative to the total number of positive 
reactions for particular allergen concentrations. 
The increase of allergen concentration to 1xSPT 
led to an increase in the rate of positive reactions 
after 24 h of exposure, however, the highest 
percentage of positive reactions were recorded 
after 48 h (38.5% and 60%, respectively). At 
allergen concentration of 10xSPT, a similar 
role for the exposure time (24 and 48 h) was 
observed, yielding 44.9% and 49.5% of positive 
reactions, respectively. Statistical comparative 
analysis revealed a signiﬁ cant difference in the 
percentage of positive results between 24-h and 
48-h time points at allergen concentrations of 
0.1xSPT (p<0.001) and 1xSPT (p<0.05). There 
was no signiﬁ cant difference in the percentage 
of positive APT reactions between 24-h and 48-h 
time points at allergen concentration of 10xSPT. 
We were unable to perform statistical analysis 
for the exposure time of 8 h because of the low 
number of positive reactions observed.
  In the group of AD patients with positive 
APT results we observed 4 different patterns of 
reaction according to time of exposure (Table 6). 
In three patients, positive reaction was recorded at 
all three time points, whereas 11 patients showed 
reaction at 24 and 48 h of exposure. Only one 
patient developed reaction at 24 h of exposure, 
whereafter the result was negative again. In two 
patients, positive reaction was only observed at 
48 h of allergen exposure. The onset of positive 
APT reaction was recorded after 8 h of exposure 
in three, at 24 h in 12, and at 48 h in two patients. 
Figure 2. Positive APT reactions at different time 
of exposure to different airborne allergen concen-
trations.
Figure 1. Relation between positive APT reaction 
and time of exposure at different allergen con-
centrations.
 We also evaluated mean serum concentrations 
of asIgE in patients with positive APT reaction 
at different time points (Table 7). The mean 
concentrations of all airborne allergens tested were 
higher with the onset at 8 and 24 h in comparison 
to the onset at 48 h of exposure.
 Characteristics of APT reaction according to 
 allergen concentrations and time of exposure
 Results of these evaluations are presented 
in Figures 3 and 4. Results for all investigated 
allergen concentrations and exposure periods were 
mostly designated as ++ (erythema, inﬂ ammatory 
inﬁ ltration and few papules). The increase in 
allergen concentration and prolongation of 
exposure period resulted in a signiﬁ cantly greater 
severity of topical reaction (p=0.0001). Results 
described as + (erythema) were considered 
nonspeciﬁ c for eczematous contact reaction and 
doubtful, thus they were not recorded as positive.
Onset of positive APT 







8 h 24 h 48 h
1 3 + + +
2 11 − + +
3 1 − + −
4 2 − − +
Total  17 3 15 16
Table 6. Onset of positive APT reaction in atopic 
dermatitis patients at allergen concentration of 
10xSPT
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NUMBER OF POSITIVE APT REACTIONS
Onset of positive APT reaction
11
 Evaluation of APT results according to the 
 evolution of positive reaction upon 
 termination of allergen exposure (6 airborne 
 allergens tested at allergen concentration 
 of 10xSPT)
  Evolution of APT reaction upon termination of 
allergen exposure is presented in Table 8. After 
8-h allergen exposure 6 positive reactions were 
recorded. They were still positive at 24 h, however, 
only 3 positive reactions were observed at 48 h. At 
72-h time point, all results were negative. Of 48 
positive results obtained at 24 h of exposure, all 
remained positive at the 48-h time point and 26 
were still positive at 72-h time point. Forty-two of 53 
positive reactions recorded after 48 h of allergen 
exposure remained positive at 72 h. In total, out of 
107 positive reactions, 68 (63.5%) persisted at the 
time point of 72 h. Intensiﬁ cation of APT reaction 
in different time-related evaluations is presented in 
Table 9. In total, out of 107 positive APT reactions 
on the ﬁ rst reading, 15 (14%) intensiﬁ ed on further 
readings.
 
 Positive APT reaction according to clinical 
 characteristics of AD patients
 Within the group of patients reporting exacer-
bations of skin inﬂ ammation after exposure to air-
borne allergens (n=25), APT reaction was positive 
in 13 and negative in 12 cases. No exacerbations 
after exposure were recorded by 11 patients, four 
patients showed positive and seven patients neg-
ative APT results. Airborne localization of skin le-
sions was observed in 27 patients, 14 of them with 
positive and 13 with negative APT reaction. Local-
ization of skin lesions within “protected” areas was 
recorded in nine patients. In this population, APT 
results were positive in three and negative in six 
Table 7. Mean concentration of asIgE (kU/l)±SD directed against selected airborne allergens in patients 
with atopic dermatitis and positive APT reaction according to exposure time
Mean concentration of asIgE (kU/l)±SD
Exposure time to 
onset of positive  
APT reaction
Number of patients 
with positive APT 
reaction
D. pteronyssinus D. farinae
8 h 1 + 1* 49.9 ± 45.05 53.1 ± 41.89
24 h 5 + 2** 53.1 ± 40.63 58.2 ± 45.11
48 h 1 19.4 12.8
 Rye grass  Timothy grass Meadow fescue  Cultivated rye
8 h 1 + 1* 55.0 ± 21.43 50.9 ±  8.84 55.5 ± 19.23 51.3 ± 22.13
24 h 5 + 2** 57.7 ± 44.67 59.8 ± 47.20 60.3 ± 43.97 60.4 ± 46.74
48 h 1 11.6 12.5 11.0 9.85
*;**these patients reacted to HDM and grass pollen allergens
Figure 3. Relation between positive APT reaction 
of different characteristics and allergen concentra-
tion used on testing.
Figure 4. Relation between positive APT results 
of different characteristics and different periods of 
exposure.
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 Results of APT in AD patients with monova- 
 lent and polyvalent airborne allergy
 Results of this analysis are presented in Table 
11. Subgroup 1 included 18 patients allergic to 
HDM; subgroup 2 included ten patients allergic to 
grass pollen allergens; and subgroup 3 included 
eight patients allergic to both HDM and grass pol-
len allergens. This analysis was performed in rela-
tion to the reactions recorded at 24 and 48 h of 
allergen exposure and concentration of 10xSPT. 
Comparative statistical analysis yielded a signiﬁ-
cantly higher percentage of positive APT reac-
tions in the group of AD patients with polyvalent 
allergy. 
Table 8. Evaluation of positive APT reactions 
upon termination of allergen exposure
Initial evaluation of 
APT results
Further evaluations of APT 
results
8 h 24 h 48 h 24 h 48 h 72 h
6 − − 6 3 0
− 48 − − 48 26
53 − − − − 42
Total number of 
positive reactions 
on initial evaluation
Total number of positive 
reactions on further 
evaluations
24h 48h 72h













Table 9. Evolution of positive APT reactions on 
different time-related evaluations
Initial evaluation at Intensiﬁcation of APT reaction
8 h 24 h 48 h 24 h 48 h 72 h
6 − − 1 0 −
− 48 − − 11 0















patients. We were not able to show any signiﬁcant 
difference in skin reactivity in APT according to lo-
calization of the skin inﬂammatory process.
 Correlation of APT results with extensive- 
 ness and severity of skin inﬂammation in 
 AD patients (W-AZS score)
 Results of APT reaction in patients with mild 
and medium severity of AD are presented in Table 
10. There was no statistically signiﬁcant difference 
in the frequency of positive APT results between 
these two subgroups of AD patients. 
Table 10. Correlation of APT results with extensiveness and severity of skin inﬂammation in 36 atopic 
dermatitis patients (W-AZS index score)
APT results
Positive Negative
 Number of patients Median
W-AZS
 Number of patients  Median
W-AZS











Mild severity of skin 
inﬂammation
W-AZS <40 points






Medium severity of skin 
inﬂammation
W-AZS >40 points






No statistically signiﬁcant between-group difference (Fisher test)
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 DISCUSSION
 Results of our study indicated that airborne al-
lergens such as HDM or grass pollen allergens 
are able to elicit eczematous skin lesions in AD 
patients when applied epicutaneously in a dose 
and time dependent way. In this study, different 
variables that may inﬂuence the outcome of APT 
were evaluated. These variables were allergen 
concentration, time of exposure to airborne aller-
gens, and reading time. Positive APT results were 
recorded in 47.2% of AD patients. Literature data 
indicate that positive APT reaction with airborne 
allergens may occur in 15%-90% of AD patients, 
depending on the methodology used on testing 
(10,16,25). In order to obtain the most natural 
skin conditions for APT in our study, we did not 
perform stripping although many authors perform 
initial stripping before the application of allergens 
(10,16,18,26). It seems to be important to note 
that in these studies stripping was performed for 
water solutions of allergens used for APT. Water 
solutions lack the occlusive conditions provided 
by ointments and therefore initial stripping may 
somehow improve skin reactivity. We decided to 
use vaseline and eucerine containing base for al-
lergens in order to obtain good skin penetration 
and permeability. Such conditions resemble the 
natural status of atopic skin, which is frequently 
being moistened and greased. Our results clearly 
indicate that this base is a good carrier for airborne 
allergens in APT reaction.    
 In the literature, various concentrations of aller-
gens ranging from 1xSPT (10,23,27) to 1000xSPT 
(28) and native powdered form (29) have been 
used. Van Voorst Vader et al. (10) concluded their 
studies with the optimal allergen concentration 
of 500xSPT and exposure time of 48 h. Accord-
ing to Langeveld-Wildschut et al. (30), allergen 
concentration should be equal to 10000 AU/ml 
(1xSPT) and increasing allergen concentration to 
1 000 000 AU/ml (10xSPT) did not signiﬁcantly in-
ﬂuence the number of patients with positive APT 
results. The authors advise to perform evaluation 
of APT after 24 and 48 h of allergen exposure, so 
that no eczematous reactions are missed. Darsow 
et al. (31) recorded a signiﬁcant increase of posi-
tive APT reactions with allergen concentration of 
10000 PNU/g in comparison to a concentration of 
1000 PNU/g when testing the same population of 
AD patients (exposure time, 48 h). Further studies 
by the same authors revealed the optimal concen-
tration of HDM allergens to be 7000 PNU/g and 
5000 PNU/g for grass pollen allergens (32). 
 Our results revealed close correlation of APT 
results with the concentration of allergens used on 
testing. For the exposure periods of 8 and 24 h, 
the increase in allergen concentration (0.1xSPT; 
1xSPT; and 10xSPT) nearly doubled the number 
of patients with positive results; at 48-h exposure 
time, the increase in allergen concentration also 
resulted in a higher number of patients with posi-
tive APT results. We recorded 199 positive results 
in total: 27 reactions at the lowest concentration, 
65 reactions at a concentration of 1xSPT, and 107 
reactions at the highest concentration of 10xSPT. 
The increase in allergen concentration also result-
ed in signiﬁcant intensiﬁcation of topical reaction. 
Therefore, we assumed that the concentration of 
0.1xSPT was too low for adequate APT reaction, 
and further analysis was focused on the other two 
allergen concentrations. The highest concentra-
tion of allergens (10xSPT) resulted in a signiﬁcant-
ly higher rate of positive APT results irrespective 
of the time of exposure in comparison to the con-
centration of 1xSPT (p<0.01 for the overall num-
Table 11. Number and percentage of positive and negative APT reactions in atopic dermatitis patients 






Patients with monovalent 
allergy
Reactions in subgroup 1 (n=72) 14 58
Reactions in subgroup 2 (n=80) 30 50
Total groups 1 and 2 (n=152) 44a 108
Patients with polyvalent allergy Reactions in subgroup 3 (n=96) 57 b 39
Patients with positive APT reaction: a/b p<0.01
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ber of positive reactions). Considering the gradual 
increase of positive APT reactions in parallel with 
the  increase of allergen concentration, and the 
highest intensity of reaction at the concentration of 
10xSPT, we chose this particular allergen concen-
tration as being most adequate for APT. Prolonga-
tion of exposure to airborne allergens used at this 
concentration did not result in any  signiﬁcant vari-
ation of APT result. The concentration of 10xSPT 
was found to be a signiﬁcant point deﬁning the mo-
ment when skin contact reactivity was getting less 
dependent on the time of exposure to airborne 
allergens. This observation should be further in-
vestigated in a larger population of AD patients.  
 Then, various periods of exposure to the se-
lected airborne allergens were analyzed accord-
ing to number of patients and total number of re-
actions. At all three concentrations of allergens, 
the highest number of patients showed reaction 
after 48 h of exposure. However, with the optimal 
concentration of allergens (10xSPT) positive reac-
tions were recorded at 24 h of exposure in 15 and 
at 48 h of exposure in 16 patients. In one patient 
allergic to HDM, we observed positive reactions 
(10xSPT) at 24 h of exposure (D. pteronyssinus 
and D. farinae allergens) and no reaction at 48 h. 
In two patients allergic to grass pollen allergens, 
positive reactions were only recorded at 48 h of 
exposure. Similar observations have been re-
ported elsewhere (10,30). Considering the total 
number of positive APT reactions, 55.8% were 
recorded at 48 h, 40.7% at 24 h and 3.5% at 8 
h of allergen exposure (p<0.01). The dynamics 
of the increase of positive reactions was clearly 
related to the concentration of allergens used on 
testing. Prolongation of exposure time from 8 to 
24 h resulted in a rapid increase of positive reac-
tions to all allergen concentrations tested. Further 
prolongation of the time of exposure (from 24 to 48 
h) resulted in the increase of positive reactions at 
lower allergen concentration. Thus, as mentioned 
above, the time of exposure appeared to be less 
important at higher concentrations used on test-
ing, and prolongation of exposure time caused an 
increase in the intensity of contact reaction. The 
latter phenomenon was not as spectacular as in 
case of allergen concentration increase, yet it was 
statistically signiﬁcant.  
 Accordingly, our study indicated that for HDM 
allergens as well as for grass pollen allergens 
the following conditions result in an optimal out-
come of APT: allergen concentration of at least 
10xSPT (500000 SBE/ml), and exposure time 
and evaluation of the reaction at 24 and 48 hours. 
 The second objective of our study was to eval-
uate the frequency of positive APT reaction in the 
population of AD patients, and to determine wheth-
er APT reaction was speciﬁc only for this population 
of patients. The frequency of positive results was 
already discussed above and we did not record 
any positive APT reaction in either control group 
(patients with allergic rhinitis and healthy volun-
teers). These results were highly expected in sub-
jects with no signs and symptoms of atopy, how-
ever, in patients with allergic respiratory diseases 
there are some data indicating APT skin reactivity 
(14,19,20,22,23,25). However, positive skin reac-
tion is generally described in the literature as ery-
thematous or urticarial, and most probably related to 
the immediate type of contact reaction. Therefore, 
it is not the same process that we are looking at. 
 The third objective was to analyze APT results 
in relation to the clinical course of AD, and to  cor-
relate APT results with total and asIgE serum con-
centrations. Twenty-ﬁve AD patients allergic to 
HDM and/or grass pollen allergens (69%) expe-
rienced exacerbations of skin inﬂammation after 
exposure to airborne allergens. In all 25 patients, 
SPT results and serum asIgE evaluations indi-
cated airborne IgE-mediated allergy to allergens 
described by the patients as “provoking” exacer-
bations of skin inﬂammation. APT results proved 
contact reactivity to the mentioned allergens in 13 
(52%) of these patients. On the other hand, four of 
11 (36%) patients who did not observe any impact 
of exposure to airborne allergens on the course 
of AD showed positive APT results. There was no 
signiﬁcant difference between these two subpopu-
lations of AD patients. Therefore, it seems that in 
order to evaluate skin contact reactivity to airborne 
allergens all patients should be tested regardless 
of the information on the exposure impact on the 
course of AD. Most probably nonspeciﬁc factors 
and constant exposure to multiple factors may 
cause difﬁculties in proper patients’ evaluation of 
the provoking exposures. Literature data on this 
topic are also conﬂicting (10,31-35). We found no 
signiﬁcant correlation between “airborne” local-
ization and APT results either, although we were 
expecting it. Again, this indicates the role of APT 
in proper evaluation of skin contact reactivity to 
airborne environmental atopens. Neither the in-
formation obtained from the patient’s case history 
nor the clinical picture of AD seems to be sufﬁcient 
in the diagnosis of airborne contact skin reactivity. 
Patients with more severe AD measured as W-
AZS score showed a higher rate of positive APT 
reaction (66.7%) in comparison to patients with 
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mild disease (40%). However, in order to evalu-
ate this phenomenon properly the population of 
AD patients should be enlarged. However, other 
authors did not record any relation between posi-
tive APT and severity of AD (36,37). Finally, we 
investigated the possible correlation of positive 
APT reaction with serum total and asIgE in AD 
patients.  Patients with positive APT had slightly 
higher concentrations of serum total and asIgE in 
comparison to patients with negative APT results, 
however, the difference was not signiﬁcant. Litera-
ture data are conﬂicting (10,18,32-33,38). Some 
authors were able to detect signiﬁcantly higher se-
rum concentrations of total and asIgE in patients 
with positive APT results (10,30), whereas others 
found no such correlation (22,32,39). We only 
found a signiﬁcantly higher rate of positive APT re-
sults in AD patients with polyvalent airborne aller-
gy in comparison to those with monovalent allergy. 
 In conclusion, APT may provide further diag-
nostic information in addition to SPT and serum 
IgE evaluations. With a standardized APT, the ac-
tual clinical relevance of IgE-mediated sensitiza-
tions for eczematous lesions might be evaluated. 
Further investigations correlating APT positive 
reaction with immunohistochemical skin analy-
sis and evaluations of the possible inﬂuence of 
selected therapeutic approaches, e.g., allergen 
speciﬁc immunotherapy, on APT results should be 
performed. 
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